Malabsorptive Procedures for Severe Obesity: Comparison of Pancreaticobiliary Bypass and Very Very Long Limb Roux-en-Y Gastric Bypass

Michel M. Murr, Bruno M. Balsiger, Frank P. Kennedy, Jane L. Mai, Michael G. Sarr

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

The aim of this study was to determine the efficacy and safety of two malabsorptive procedures for severe obesity. Prospectively collected data from eight men and three women who underwent partial biliopancreatic bypass (PBB) and 19 men and seven women who underwent very very long limb Roux-en-Y gastric bypass (VVLGB) for superobesity (preoperative weight >225% above ideal body weight) were evaluated. Age (42 ± 3 years and 40 ± 2 years), body mass index (64 ± 4 kg/m2 and 67 ± 3 kg/m2), and percentage of excess body weight (183% ± 17% and 203% ± 12%) were similar (mean ± standard, error of the mean). Median follow-up was 96 months (range 72 to 108 months) and 24 months (range 18 to 60 months) for the PBB and VVLGB groups, respectively. Weight loss expressed as percentage of excess body weight was 68% ± 4% 2 years and 71% ± 5% 4 years after PBB, and 53% ± 7% 2 years and 57% ± 5 % 4 years after VVLGB. Current body mass indexes are 37 ± 2 kg/m2 and 42 ± 2 kg/m2 in the PBB and VVLGB groups, respectively. Hospital mortality was zero. Morbidity occurred in five patients after VVLGB (wound infection in four, wound seroma in one, and pulmonary embolus in one) and in two patients after PBB (abscess in two, anastomotic leak in one, and gastrointestinal bleeding in one). After PBB, one woman died of refractory liver failure 18 months postoperatively and two other patients developed metabolic bone disease. No such known complications have occurred to date after VVLGB. We conclude that VVLGB is safe and effective for clinically significant obesity, results in sustained weight loss, and improves quality of life. (J GASTROINTEST SURG 1999;3:607-612.).

Original languageEnglish (US)
Pages (from-to)607-612
Number of pages6
JournalJournal of Gastrointestinal Surgery
Volume3
Issue number6
StatePublished - Nov 1999

Fingerprint

Biliopancreatic Diversion
Gastric Bypass
Morbid Obesity
Extremities
Weight Loss
Body Mass Index
Body Weight
Seroma
Ideal Body Weight
Anastomotic Leak
Metabolic Bone Diseases
Liver Failure
Wound Infection
Hospital Mortality
Embolism
Abscess
Obesity
Quality of Life
Hemorrhage
Morbidity

Keywords

  • Bariatric surgery
  • Gastric bypass
  • Malabsorption
  • Morbid obesity
  • Obesity

ASJC Scopus subject areas

  • Surgery

Cite this

Malabsorptive Procedures for Severe Obesity : Comparison of Pancreaticobiliary Bypass and Very Very Long Limb Roux-en-Y Gastric Bypass. / Murr, Michel M.; Balsiger, Bruno M.; Kennedy, Frank P.; Mai, Jane L.; Sarr, Michael G.

In: Journal of Gastrointestinal Surgery, Vol. 3, No. 6, 11.1999, p. 607-612.

Research output: Contribution to journalArticle

Murr, Michel M. ; Balsiger, Bruno M. ; Kennedy, Frank P. ; Mai, Jane L. ; Sarr, Michael G. / Malabsorptive Procedures for Severe Obesity : Comparison of Pancreaticobiliary Bypass and Very Very Long Limb Roux-en-Y Gastric Bypass. In: Journal of Gastrointestinal Surgery. 1999 ; Vol. 3, No. 6. pp. 607-612.
@article{9b70547615224ddda771af633b7121ab,
title = "Malabsorptive Procedures for Severe Obesity: Comparison of Pancreaticobiliary Bypass and Very Very Long Limb Roux-en-Y Gastric Bypass",
abstract = "The aim of this study was to determine the efficacy and safety of two malabsorptive procedures for severe obesity. Prospectively collected data from eight men and three women who underwent partial biliopancreatic bypass (PBB) and 19 men and seven women who underwent very very long limb Roux-en-Y gastric bypass (VVLGB) for superobesity (preoperative weight >225{\%} above ideal body weight) were evaluated. Age (42 ± 3 years and 40 ± 2 years), body mass index (64 ± 4 kg/m2 and 67 ± 3 kg/m2), and percentage of excess body weight (183{\%} ± 17{\%} and 203{\%} ± 12{\%}) were similar (mean ± standard, error of the mean). Median follow-up was 96 months (range 72 to 108 months) and 24 months (range 18 to 60 months) for the PBB and VVLGB groups, respectively. Weight loss expressed as percentage of excess body weight was 68{\%} ± 4{\%} 2 years and 71{\%} ± 5{\%} 4 years after PBB, and 53{\%} ± 7{\%} 2 years and 57{\%} ± 5 {\%} 4 years after VVLGB. Current body mass indexes are 37 ± 2 kg/m2 and 42 ± 2 kg/m2 in the PBB and VVLGB groups, respectively. Hospital mortality was zero. Morbidity occurred in five patients after VVLGB (wound infection in four, wound seroma in one, and pulmonary embolus in one) and in two patients after PBB (abscess in two, anastomotic leak in one, and gastrointestinal bleeding in one). After PBB, one woman died of refractory liver failure 18 months postoperatively and two other patients developed metabolic bone disease. No such known complications have occurred to date after VVLGB. We conclude that VVLGB is safe and effective for clinically significant obesity, results in sustained weight loss, and improves quality of life. (J GASTROINTEST SURG 1999;3:607-612.).",
keywords = "Bariatric surgery, Gastric bypass, Malabsorption, Morbid obesity, Obesity",
author = "Murr, {Michel M.} and Balsiger, {Bruno M.} and Kennedy, {Frank P.} and Mai, {Jane L.} and Sarr, {Michael G.}",
year = "1999",
month = "11",
language = "English (US)",
volume = "3",
pages = "607--612",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Malabsorptive Procedures for Severe Obesity

T2 - Comparison of Pancreaticobiliary Bypass and Very Very Long Limb Roux-en-Y Gastric Bypass

AU - Murr, Michel M.

AU - Balsiger, Bruno M.

AU - Kennedy, Frank P.

AU - Mai, Jane L.

AU - Sarr, Michael G.

PY - 1999/11

Y1 - 1999/11

N2 - The aim of this study was to determine the efficacy and safety of two malabsorptive procedures for severe obesity. Prospectively collected data from eight men and three women who underwent partial biliopancreatic bypass (PBB) and 19 men and seven women who underwent very very long limb Roux-en-Y gastric bypass (VVLGB) for superobesity (preoperative weight >225% above ideal body weight) were evaluated. Age (42 ± 3 years and 40 ± 2 years), body mass index (64 ± 4 kg/m2 and 67 ± 3 kg/m2), and percentage of excess body weight (183% ± 17% and 203% ± 12%) were similar (mean ± standard, error of the mean). Median follow-up was 96 months (range 72 to 108 months) and 24 months (range 18 to 60 months) for the PBB and VVLGB groups, respectively. Weight loss expressed as percentage of excess body weight was 68% ± 4% 2 years and 71% ± 5% 4 years after PBB, and 53% ± 7% 2 years and 57% ± 5 % 4 years after VVLGB. Current body mass indexes are 37 ± 2 kg/m2 and 42 ± 2 kg/m2 in the PBB and VVLGB groups, respectively. Hospital mortality was zero. Morbidity occurred in five patients after VVLGB (wound infection in four, wound seroma in one, and pulmonary embolus in one) and in two patients after PBB (abscess in two, anastomotic leak in one, and gastrointestinal bleeding in one). After PBB, one woman died of refractory liver failure 18 months postoperatively and two other patients developed metabolic bone disease. No such known complications have occurred to date after VVLGB. We conclude that VVLGB is safe and effective for clinically significant obesity, results in sustained weight loss, and improves quality of life. (J GASTROINTEST SURG 1999;3:607-612.).

AB - The aim of this study was to determine the efficacy and safety of two malabsorptive procedures for severe obesity. Prospectively collected data from eight men and three women who underwent partial biliopancreatic bypass (PBB) and 19 men and seven women who underwent very very long limb Roux-en-Y gastric bypass (VVLGB) for superobesity (preoperative weight >225% above ideal body weight) were evaluated. Age (42 ± 3 years and 40 ± 2 years), body mass index (64 ± 4 kg/m2 and 67 ± 3 kg/m2), and percentage of excess body weight (183% ± 17% and 203% ± 12%) were similar (mean ± standard, error of the mean). Median follow-up was 96 months (range 72 to 108 months) and 24 months (range 18 to 60 months) for the PBB and VVLGB groups, respectively. Weight loss expressed as percentage of excess body weight was 68% ± 4% 2 years and 71% ± 5% 4 years after PBB, and 53% ± 7% 2 years and 57% ± 5 % 4 years after VVLGB. Current body mass indexes are 37 ± 2 kg/m2 and 42 ± 2 kg/m2 in the PBB and VVLGB groups, respectively. Hospital mortality was zero. Morbidity occurred in five patients after VVLGB (wound infection in four, wound seroma in one, and pulmonary embolus in one) and in two patients after PBB (abscess in two, anastomotic leak in one, and gastrointestinal bleeding in one). After PBB, one woman died of refractory liver failure 18 months postoperatively and two other patients developed metabolic bone disease. No such known complications have occurred to date after VVLGB. We conclude that VVLGB is safe and effective for clinically significant obesity, results in sustained weight loss, and improves quality of life. (J GASTROINTEST SURG 1999;3:607-612.).

KW - Bariatric surgery

KW - Gastric bypass

KW - Malabsorption

KW - Morbid obesity

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=0033220283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033220283&partnerID=8YFLogxK

M3 - Article

C2 - 10554367

AN - SCOPUS:0033220283

VL - 3

SP - 607

EP - 612

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 6

ER -